At 100% sensitivity, the specificity of diagnosing stage IA OC versus benign ovarian tumors was 63.6% compared to either annexin A2 (3.6% specificity) or CA125 (20% specificity) alone (Table 3). The gene discussed is MUC16; the disease is ovarian benign neoplasm.